Inhibition of p38-MK2 pathway enhances the efficacy of microtubule inhibitors in breast cancer cells
Microtubule-targeting agents (MTAs) are widely used as first- and second-line chemotherapies for various cancers. However, current MTAs exhibit positive responses only in subsets of patients and are often accompanied by side effects due to their impact on normal cells. This underscores an urgent nee...
I tiakina i:
| Ngā kaituhi matua: | , , , , , , , , , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
eLife Sciences Publications Ltd
2025-05-01
|
| Rangatū: | eLife |
| Ngā marau: | |
| Urunga tuihono: | https://elifesciences.org/articles/104859 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|